Portland, OR, March 30, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global herpes simplex virus treatment market was estimated at $1.72 billion in 2021 and is expected to hit $2.12 billion by 2031, registering a CAGR of 2.1% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Request Sample, PDF Brochure- https://www.alliedmarketresearch.com/request-sample/13568
Report coverage & details:
| Forecast Period | 2022–2031 |
| Base Year | 2021 |
| Market Size in 2021 | $1.72 Billion |
| Market Size in 2031 | $2.12 Billion |
| CAGR | 2.1% |
| No. of Pages in Report | 349 |
| Segments Covered | Type, Drug Type, Distribution Channel, and Region. |
| Drivers | Rise in the prevalence of herpes simplex virus (HSV) infection |
| Restraints | Less awareness about the herpes simplex virus in the underdeveloped countries |
| Limited number of drugs available for treating HSV infections | |
| Opportunity | Increase in R&D activities |
Impact of COVID-19 on Herpes Simplex Virus Treatment Market-
- During the pandemic, there was a surge in cases of HSV infections which resulted in a higher demand for antiviral drugs such as acyclovir. This situation also highlighted the significance of personal hygiene and the spread of infectious diseases, leading to a moderately positive impact on the market.
- However, the COVID-19 pandemic disrupted or delayed many clinical trials aimed at developing treatments for HSV. As a result, the development of new treatments was slowed down and there was limited availability of clinical data to support regulatory approvals.
Procure Complete Report (349 Pages PDF with Insights, Charts, Tables, and Figures)
https://www.alliedmarketresearch.com/checkout-final/herpes-simplex-virus-treatment-market
The global herpes simplex virus treatment market is analyzed across type, drug type, distribution channel, and region. The report uses tabular and graphical representation to provide a detailed study of the segments and their sub-segments. These segmentations assist investors and market participants in developing strategies based on the top revenue-generating and fastest-growing segments identified in the research.
By type, the herpes simplex virus-1 infection segment held the largest share in 2021, garnering nearly three-fourths of the global herpes simplex virus treatment market revenue. The herpes simplex virus-2 infection segment, on the other hand, would register the fastest CAGR of 2.6% during the forecast period.
By drug type, the valacyclovir segment contributed to nearly three-fifths of the global herpes simplex virus treatment market share in 2021. The same segment would also register the fastest CAGR of 2.3% during the forecast period.
By distribution channel, the drug store and retail pharmacies segment accounted for the highest share in 2021, generating more than two-thirds of the global herpes simplex virus treatment market revenue. The online providers segment, however, would register the fastest CAGR of 3.1% during the forecast period.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/13568
By region, North America held the major share in 2021, garnering nearly two-fifths of the global herpes simplex virus treatment market revenue. Asia-Pacific, simultaneously, would showcase the fastest CAGR of 2.8% from 2022 to 2031. The other provinces studied through the report include Europe and LAMEA.
The key market players analyzed in the global herpes simplex virus treatment market report include Abbott Laboratories, Emcure Pharmaceuticals Limited, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Glenmark Pharmaceuticals Limited, Pfizer Inc., Amneal Pharmaceuticals LLC., Novartis AG, Teva Pharmaceutical Industries Ltd., and Viatris Inc.
These market players have embraced several strategies including product approval and new launches to highlight their prowess in the industry. The report is helpful in formulating the business performance and developments by the top players.
Similar Research Reports for Information, Communication and Technology:
Meniscus Repair System Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
High Frequency Ventilators Market- Global Opportunity Analysis and Industry Forecast, 2021–2030
Motorized Prosthesis Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
Local Anesthesia Drugs Market - Global Opportunity Analysis and Industry Forecast, 2021–2030
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
